Featured Publications
The Vascular Quality Initiative assessment of the Bard Lifestent for the treatment of popliteal artery occlusive disease
Bertges D, Eldrup-Jorgensen J, Eskandari M, Hamdan A, Mena-Hurtado C, Mewissen M, Smith T, Woo E, Cronenwett J, Initiative S. The Vascular Quality Initiative assessment of the Bard Lifestent for the treatment of popliteal artery occlusive disease. Journal Of Vascular Surgery 2023, 78: 1489-1496.e1. PMID: 37648091, DOI: 10.1016/j.jvs.2023.08.122.Peer-Reviewed Original ResearchConceptsTarget lesion revascularizationChronic limb-threatening ischemiaTarget vessel revascularizationMajor adverse eventsLimb-threatening ischemiaPopliteal arteryLesion revascularizationMajor amputationVessel revascularizationHemodynamic successSecondary patencyAdverse eventsOcclusive diseaseProcedural successSingle-arm prospective studyProximal popliteal arterySustained clinical successPrimary efficacy outcomePrimary safety outcomeArtery occlusive diseaseComposite primary endpointPrimary-assisted patencyKaplan-Meier analysisSuperficial femoral arteryMajority of stents
2022
The Vascular Quality Initiative Assessment of the Bard Lifestent for the Treatment of Popliteal Artery Occlusive Disease
Bertges D, Eldrup-Jorgensen J, Eskandari M, Mena C, Mewissen M, Smith T, Woo E, Cronenwett J. The Vascular Quality Initiative Assessment of the Bard Lifestent for the Treatment of Popliteal Artery Occlusive Disease. Journal Of Vascular Surgery 2022, 76: e103-e104. DOI: 10.1016/j.jvs.2022.07.083.Peer-Reviewed Original Research